Long-Term Outcomes from Cytori Cell Therapy Trial for Heart Failure Published ... MarketWatch SAN DIEGO, Apr 14, 2014 (BUSINESS WIRE) -- Cytori Therapeutics (NASDAQ:CYTX) today announced publication of safety and efficacy data from a 36 month European clinical trial of Cytori Cell Therapy in patients with chronic ischemic heart failure. |
